Antonio Brazil Viana Júnior
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Antonio Brazil Viana Júnior has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Danielle Pessoa Lima
Universidade Federal do Ceará
7 shared publications - Pedro Braga-Neto
Clinical Medicine, Universidade Federal do Ceara, Rua Professor Costa Mendes 1608, 4th floor, Rodolfo Teofilo, Fortaleza, CE, 60430-140, Brazil
7 shared publications - Jarbas de Sá Roriz Filho
Department of Internal Medicine, Division of Geriatrics Federal University of Ceará Fortaleza Ceará Brazil
5 shared publications - Manoel Alves Sobreira-Neto
Universidade Federal do Ceará, Faculdade de Medicina, Fortaleza CE, Brazil
4 shared publications - Samuel Brito de Almeida
Universidade Federal do Ceará, Hospital Univerisátio Walter Cantídio, Unidade de Pesquisa Clínica, Fortaleza CE, Brazil
4 shared publications - Elodie Bomfim Hyppolito
Universidade Federal do Ceará
3 shared publications
Latest Publications
- 2 September 2026
- Published by Revista CPAQV in Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida
- Vol. 18 (3)
MÁSCARA WOLF VERSUS MÁSCARA FACIAL TOTAL CONVENCIONAL NA VENTILAÇÃO NÃO INVASIVA APÓS CIRURGIA CARDÍACA: COMPARAÇÃO RANDOMIZADA E CONTROLADA DE EFICIÊNCIA MECÂNICA E CONFORTO
Fundamentos: A ventilação não invasiva é central na prevenção de complicações pulmonares após a cirurgia cardíaca, e a interface por meio da qual a pressão positiva é aplicada constitui determinante decisivo de sua eficácia. As interfaces faciais totais reduzem o escape aéreo periférico, mas as comparações controladas entre elas são escassas, e a suposição de que apresentam desempenho equivalente não havia sido testada neste cenário. A máscara Wolf é uma interface facial total desenvolvida no Brasil, sem evidência controlada prévia após cirurgia cardíaca. Este estudo comparou a máscara Wolf com uma máscara facial total convencional quanto à eficiência mecânica e ao conforto como desfechos primários, e às complicações pulmonares e à oxigenação como desfechos secundários.Métodos: Ensaio clínico randomizado e controlado, prospectivo, conduzido em unidade de terapia intensiva cardíaca, no qual pacientes submetidos a cirurgia eletiva coronariana ou valvar foram randomizados para a máscara Wolf (n = 29) ou para uma máscara facial total convencional (n = 28), em três sessões diárias de 60 minutos até a alta. Avaliaramse a pressão de suporte inspiratória necessária para alcançar volume corrente de 6 mL/kg de peso corporal ideal, o conforto por escala visual analógica, as complicações pulmonares e a gasometria arterial. As variáveis contínuas foram comparadas pelo teste de Mann-Whitney e as categóricas pelo teste do qui-quadrado ou exato de Fisher. Resultados: A máscara Wolf exigiu pressão de suporte inspiratória significativamente menor para alcançar o mesmo volume corrente-alvo (5,6 ± 2,1 versus 7,6 ± 2,1 cm H2O; diferença de 1,99 cm H2O, IC95% 0,87 a 3,10; P = 0,002) e obteve escores de conforto mais elevados (mediana 10,0 [IIQ 9,0-10,0] versus 8,0 [IIQ 7,8-9,0]; diferença de 2,0 pontos, IC95% 0,5 a 2,0; P < 0,001). As complicações pulmonares não diferiram de forma significativa: a máscara Wolf não registrou atelectasia bibasal (0% versus 3,6%) e teve mais pacientes livres de complicação (86% versus 79%), comparação exploratória e sem poder estatístico definido. A oxigenação foi comparável, sem hipercapnia ou acidose. Conclusões: Após cirurgia cardíaca, a máscara Wolf ofereceu suporte ventilatório equivalente ao de uma máscara facial total convencional com menor pressão aplicada e maior conforto, preservando a oxigenação e a segurança ácido-base. Constitui alternativa facial total eficiente para a ventilação não invasiva nesta população. Registro do ensaio: Registro Brasileiro de Ensaios Clínicos (ReBEC), https://ensaiosclinicos.gov.br/rg/RBR-2nzg6bj, RBR-2nzg6bj.
- 2 September 2026
- Published by Revista CPAQV in Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida
- Vol. 18 (3)
MÁSCARA WOLF VERSUS MÁSCARA FACIAL TOTAL CONVENCIONAL NA VENTILAÇÃO NÃO INVASIVA APÓS CIRURGIA CARDÍACA: COMPARAÇÃO RANDOMIZADA E CONTROLADA DE EFICIÊNCIA MECÂNICA E CONFORTO
Fundamentos: A ventilação não invasiva é central na prevenção de complicações pulmonares após a cirurgia cardíaca, e a interface por meio da qual a pressão positiva é aplicada constitui determinante decisivo de sua eficácia. As interfaces faciais totais reduzem o escape aéreo periférico, mas as comparações controladas entre elas são escassas, e a suposição de que apresentam desempenho equivalente não havia sido testada neste cenário. A máscara Wolf é uma interface facial total desenvolvida no Brasil, sem evidência controlada prévia após cirurgia cardíaca. Este estudo comparou a máscara Wolf com uma máscara facial total convencional quanto à eficiência mecânica e ao conforto como desfechos primários, e às complicações pulmonares e à oxigenação como desfechos secundários.Métodos: Ensaio clínico randomizado e controlado, prospectivo, conduzido em unidade de terapia intensiva cardíaca, no qual pacientes submetidos a cirurgia eletiva coronariana ou valvar foram randomizados para a máscara Wolf (n = 29) ou para uma máscara facial total convencional (n = 28), em três sessões diárias de 60 minutos até a alta. Avaliaramse a pressão de suporte inspiratória necessária para alcançar volume corrente de 6 mL/kg de peso corporal ideal, o conforto por escala visual analógica, as complicações pulmonares e a gasometria arterial. As variáveis contínuas foram comparadas pelo teste de Mann-Whitney e as categóricas pelo teste do qui-quadrado ou exato de Fisher. Resultados: A máscara Wolf exigiu pressão de suporte inspiratória significativamente menor para alcançar o mesmo volume corrente-alvo (5,6 ± 2,1 versus 7,6 ± 2,1 cm H2O; diferença de 1,99 cm H2O, IC95% 0,87 a 3,10; P = 0,002) e obteve escores de conforto mais elevados (mediana 10,0 [IIQ 9,0-10,0] versus 8,0 [IIQ 7,8-9,0]; diferença de 2,0 pontos, IC95% 0,5 a 2,0; P < 0,001). As complicações pulmonares não diferiram de forma significativa: a máscara Wolf não registrou atelectasia bibasal (0% versus 3,6%) e teve mais pacientes livres de complicação (86% versus 79%), comparação exploratória e sem poder estatístico definido. A oxigenação foi comparável, sem hipercapnia ou acidose. Conclusões: Após cirurgia cardíaca, a máscara Wolf ofereceu suporte ventilatório equivalente ao de uma máscara facial total convencional com menor pressão aplicada e maior conforto, preservando a oxigenação e a segurança ácido-base. Constitui alternativa facial total eficiente para a ventilação não invasiva nesta população. Registro do ensaio: Registro Brasileiro de Ensaios Clínicos (ReBEC), https://ensaiosclinicos.gov.br/rg/RBR-2nzg6bj, RBR-2nzg6bj.
- Open Access
- 27 February 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (02) , 001-011
Clinical correlates of physical performance and sarcopenia in Parkinson's disease: a cross-sectional study
Parkinson's disease (PD) presents motor and non-motor symptoms that impair function and quality of life. Identifying clinical factors linked to physical performance is key for patient care and management. To examine associations between sarcopenia-related measures and physical performance in mild-to-moderate PD (Hoehn & Yahr [HY] I–III). This was a cross-sectional study including patients with idiopathic Parkinson's disease at mild to moderate stages (Hoehn & Yahr I–III), evaluated in the ON medication state. Physical performance was assessed using the Short Physical Performance Battery (SPPB). Sarcopenia was evaluated according to the revised European Working Group on Sarcopenia in Older People (EWGSOP2) consensus, including screening with the SARC-F questionnaire and the Ishii score, assessment of muscle strength by handgrip dynamometry, and evaluation of body composition and appendicular lean mass by whole-body dual-energy X-ray absorptiometry (DXA). Analyses included bivariate comparisons, correlation analyses, and logistic regression models (Enter and Best Subsets). A total of 127 patients were evaluated (mean age 66 years; 41.7% females). Low physical performance was observed in 39% (n = 50) of patients and was strongly associated with positive screening of sarcopenia (SARC-F score ≥ 4; odds ratio [OR]: 1.67; 95%CI: 1.30–2.15; p < 0.001). Ishii score (p = 0.009), reduced mean handgrip strength (26 ± 10 kgf versus 30 ± 10 kgf; p = 0.02), and postural instability and gait difficulty (PIGD) (p < 0.001) were also significantly associated with low SPPB performance in bivariate analyses. In the multivariable models, SARC-F and PIGD emerged as independent predictors of poor physical performance. The best subset model, combining SARC-F and PIGD, showed good discriminative accuracy (area under the curve [AUC] = 0.82). Higher PIGD scores and SARC-F ≥ 4 correlated with poor physical performance in PD. Low performance was linked to both SARC-F and Ishii scores, which help identify risk of functional decline. Longitudinal studies are needed to clarify causality and treatment implications.
- 27 February 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (02) , 001-011
Open AccessClinical correlates of physical performance and sarcopenia in Parkinson's disease: a cross-sectional study
Parkinson's disease (PD) presents motor and non-motor symptoms that impair function and quality of life. Identifying clinical factors linked to physical performance is key for patient care and management. To examine associations between sarcopenia-related measures and physical performance in mild-to-moderate PD (Hoehn & Yahr [HY] I–III). This was a cross-sectional study including patients with idiopathic Parkinson's disease at mild to moderate stages (Hoehn & Yahr I–III), evaluated in the ON medication state. Physical performance was assessed using the Short Physical Performance Battery (SPPB). Sarcopenia was evaluated according to the revised European Working Group on Sarcopenia in Older People (EWGSOP2) consensus, including screening with the SARC-F questionnaire and the Ishii score, assessment of muscle strength by handgrip dynamometry, and evaluation of body composition and appendicular lean mass by whole-body dual-energy X-ray absorptiometry (DXA). Analyses included bivariate comparisons, correlation analyses, and logistic regression models (Enter and Best Subsets). A total of 127 patients were evaluated (mean age 66 years; 41.7% females). Low physical performance was observed in 39% (n = 50) of patients and was strongly associated with positive screening of sarcopenia (SARC-F score ≥ 4; odds ratio [OR]: 1.67; 95%CI: 1.30–2.15; p < 0.001). Ishii score (p = 0.009), reduced mean handgrip strength (26 ± 10 kgf versus 30 ± 10 kgf; p = 0.02), and postural instability and gait difficulty (PIGD) (p < 0.001) were also significantly associated with low SPPB performance in bivariate analyses. In the multivariable models, SARC-F and PIGD emerged as independent predictors of poor physical performance. The best subset model, combining SARC-F and PIGD, showed good discriminative accuracy (area under the curve [AUC] = 0.82). Higher PIGD scores and SARC-F ≥ 4 correlated with poor physical performance in PD. Low performance was linked to both SARC-F and Ishii scores, which help identify risk of functional decline. Longitudinal studies are needed to clarify causality and treatment implications.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 68, e31
Clostridioides difficile infections in seven Brazilian hospitals during the COVID-19 pandemic: hand hygiene and antimicrobial consumption
This study aimed to evaluate the incidence density of Clostridioides difficile infections (CDIs), hand hygiene adherence, and antimicrobial consumption across Brazilian hospitals during the COVID-19 pandemic. An ecological study was conducted in seven Brazilian hospitals from June 2018 to December 2019 (pre-pandemic) and from June 2020 to December 2021(pandemic). Data on CDI incidence density, hand hygiene adherence, and antimicrobial consumption were collected. CDI incidence was assessed based on the number of monthly cases and the incidence density rate per 10,000 patient-days. This study involved hospitals from four states and included three public and four private institutions. Statistical analyses were performed using the Mann-Whitney U test in R (p < 0.05). Time series analysis used joinpoint regression to determine monthly percent change, average monthly percent change, and 95% confidence intervals. Although statistically insignificant, an upward trend occurred in CDI incidence (p = 0.081) from the pre-pandemic to the pandemic periods. Consumption of azithromycin (p < 0.01) and levofloxacin (p < 0.01) increased significantly, whereas ceftriaxone use decreased (p = 0.0038). The joinpoint regression analysis of antimicrobial consumption trends during the pandemic showed trend changes for vancomycin and meropenem defined daily dose, with higher consumption during the second wave of COVID-19 in Brazil. Hand hygiene adherence failed to differ significantly but showed a downward trend in 2020 and 2021. The dynamics of the COVID-19 pandemic and changes in protective measures may have influenced CDI incidence and antimicrobial consumption patterns across the study period.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 68, e31
Open AccessClostridioides difficile infections in seven Brazilian hospitals during the COVID-19 pandemic: hand hygiene and antimicrobial consumption
This study aimed to evaluate the incidence density of Clostridioides difficile infections (CDIs), hand hygiene adherence, and antimicrobial consumption across Brazilian hospitals during the COVID-19 pandemic. An ecological study was conducted in seven Brazilian hospitals from June 2018 to December 2019 (pre-pandemic) and from June 2020 to December 2021(pandemic). Data on CDI incidence density, hand hygiene adherence, and antimicrobial consumption were collected. CDI incidence was assessed based on the number of monthly cases and the incidence density rate per 10,000 patient-days. This study involved hospitals from four states and included three public and four private institutions. Statistical analyses were performed using the Mann-Whitney U test in R (p < 0.05). Time series analysis used joinpoint regression to determine monthly percent change, average monthly percent change, and 95% confidence intervals. Although statistically insignificant, an upward trend occurred in CDI incidence (p = 0.081) from the pre-pandemic to the pandemic periods. Consumption of azithromycin (p < 0.01) and levofloxacin (p < 0.01) increased significantly, whereas ceftriaxone use decreased (p = 0.0038). The joinpoint regression analysis of antimicrobial consumption trends during the pandemic showed trend changes for vancomycin and meropenem defined daily dose, with higher consumption during the second wave of COVID-19 in Brazil. Hand hygiene adherence failed to differ significantly but showed a downward trend in 2020 and 2021. The dynamics of the COVID-19 pandemic and changes in protective measures may have influenced CDI incidence and antimicrobial consumption patterns across the study period.
- 28 November 2025
- Published by Wiley in Hepatology Research
- Vol. 56 (3) , 339-350
Autoimmune Hepatitis Profiles After Liver Transplantation in Latin American Patients: A Cluster Analysis of Clinical Outcomes
Aim: Most existing evidence regarding liver transplantation (LT) for autoimmune hepatitis (AIH) originates from European cohorts, hindering the applicability of current guidelines to other populations because of possible geographic variations. There is an urgent need for region‐specific prognostic models. Methods: We analyzed 164 AIH patients from Brazil and Venezuela undergoing LT between 2002 and 2025, the largest AIH LT cohort from Latin America to date. Random survival forests (RSF) identified key predictors of overall survival (OS), graft survival (GS), and AIH recurrence (rAIH). Clustering based on predicted risks identified high‐risk groups with significantly worse outcomes ( p < 0.001 for all). Penalized models with the most important variables from the RSF assessed risk stratification. Results: 5‐, 10‐, and 20‐year OS were 83%, 78%, and 49%. rAIH rates increased from 6% at 5 years to 34% at 20 years. Mycophenolate sodium use in maintenance therapy was ranked as the most important factor for OS (Hazard ratio [HR] = 0.44) and GS (HR = 0.46) prediction, while younger age was the most important risk factor for rAIH. LASSO models accurately predicted early outcomes (1‐year AUCs: OS 0.73, GS 0.73, rAIH 0.81). In a landmark analysis (6 months post‐LT), infectious complications emerged as the main determinant for long‐term OS, and a new model improved 5‐ and 10‐year OS prediction (AUCs: 0.76 and 0.79, respectively). Conclusion: This analysis identifies key predictors that define high‐risk clusters for early and long‐term outcomes in Latin American AIH patients post‐LT, highlighting potential region‐specific factors.
- 28 November 2025
- Published by Wiley in Hepatology Research
- Vol. 56 (3) , 339-350
Autoimmune Hepatitis Profiles After Liver Transplantation in Latin American Patients: A Cluster Analysis of Clinical Outcomes
Aim: Most existing evidence regarding liver transplantation (LT) for autoimmune hepatitis (AIH) originates from European cohorts, hindering the applicability of current guidelines to other populations because of possible geographic variations. There is an urgent need for region‐specific prognostic models. Methods: We analyzed 164 AIH patients from Brazil and Venezuela undergoing LT between 2002 and 2025, the largest AIH LT cohort from Latin America to date. Random survival forests (RSF) identified key predictors of overall survival (OS), graft survival (GS), and AIH recurrence (rAIH). Clustering based on predicted risks identified high‐risk groups with significantly worse outcomes ( p < 0.001 for all). Penalized models with the most important variables from the RSF assessed risk stratification. Results: 5‐, 10‐, and 20‐year OS were 83%, 78%, and 49%. rAIH rates increased from 6% at 5 years to 34% at 20 years. Mycophenolate sodium use in maintenance therapy was ranked as the most important factor for OS (Hazard ratio [HR] = 0.44) and GS (HR = 0.46) prediction, while younger age was the most important risk factor for rAIH. LASSO models accurately predicted early outcomes (1‐year AUCs: OS 0.73, GS 0.73, rAIH 0.81). In a landmark analysis (6 months post‐LT), infectious complications emerged as the main determinant for long‐term OS, and a new model improved 5‐ and 10‐year OS prediction (AUCs: 0.76 and 0.79, respectively). Conclusion: This analysis identifies key predictors that define high‐risk clusters for early and long‐term outcomes in Latin American AIH patients post‐LT, highlighting potential region‐specific factors.
- 31 March 2025
- Published by Portuguese Association of Nutritionists in Acta Portuguesa de Nutrição
- Vol. 40, 30-35
Impacto da síndrome metabólica no transplante autólogo de células tronco hematopoiéticas
Introdução: Entre as possíveis complicações em pacientes submetidos ao transplante de células-tronco hematopoiéticas estão os distúrbios metabólicos. Objetivos: verificar a prevalência de síndrome metabólica e de seus componentes entre os pacientes internados para a realização do transplante de células-tronco hematopoiéticas e seu impacto no tempo de hospitalização, complicações e desfecho clínico. Metodologia: Pesquisa transversal, quantitativa. Foram incluídos participantes de ambos os sexos, maiores de 18 anos, submetidos pela primeira vez ao transplante de células-tronco hematopoiéticas autólogo no período de 2019 a 2023. Foram excluídos do estudo indivíduos com menos de 18 anos, com limitações físicas para realizar as medidas antropométricas e os que apresentaram infecção por COVID-19 durante o internamento. Foram recolhidos dados clínicos, demográficos, laboratoriais, antropométricos, complicações durante o internamento e desfecho clínico. A síndrome metabólica foi identificada segundo o National Cholesterol Education Program. As análises estatísticas foram realizadas utilizando o programa estatístico R, com nível de significância de 5%. Resultados: A amostra foi composta por 173 pacientes, maioria do sexo feminino (53,2%) e diagnóstico de mieloma múltiplo (54,9%). A síndrome metabólica foi diagnosticada em 53,4% (n=79) dos pacientes. Encontrou-se circunferência da cintura elevada em 65,7%, hipertrigliceridemia em 50,3%, pressão arterial sistólica elevada em 49,7%, HDL-c baixo em 49%, pressão arterial diastólica elevada em 38,7% e hiperglicemia em 12,4%. A obesidade abdominal esteve mais associada ao género feminino (p< 0,001). Encontrou-se significativamente, maior média de idade no grupo diagnosticado com síndrome metabólica, obesidade abdominal, pressão arterial sistólica alta e hipertrigliceridemia (p< 0,05). A presença de infecção durante o internamento foi associada significativamente a pressão diastólica alta (p= 0,022). Não foram encontradas associações significativas entre a síndrome metabólica ou seus componentes com o tempo de hospitalização. Conclusões: Este estudo revelou alta prevalência de síndrome metabólica e de seus componentes em pacientes submetidos ao transplante de células-tronco hematopoiéticas autólogo. Entretanto, não foi encontrada associação entre a síndrome metabólica e o tempo de hospitalização.
- 31 March 2025
- Published by Portuguese Association of Nutritionists in Acta Portuguesa de Nutrição
- Vol. 40, 30-35
Impacto da síndrome metabólica no transplante autólogo de células tronco hematopoiéticas
Introdução: Entre as possíveis complicações em pacientes submetidos ao transplante de células-tronco hematopoiéticas estão os distúrbios metabólicos. Objetivos: verificar a prevalência de síndrome metabólica e de seus componentes entre os pacientes internados para a realização do transplante de células-tronco hematopoiéticas e seu impacto no tempo de hospitalização, complicações e desfecho clínico. Metodologia: Pesquisa transversal, quantitativa. Foram incluídos participantes de ambos os sexos, maiores de 18 anos, submetidos pela primeira vez ao transplante de células-tronco hematopoiéticas autólogo no período de 2019 a 2023. Foram excluídos do estudo indivíduos com menos de 18 anos, com limitações físicas para realizar as medidas antropométricas e os que apresentaram infecção por COVID-19 durante o internamento. Foram recolhidos dados clínicos, demográficos, laboratoriais, antropométricos, complicações durante o internamento e desfecho clínico. A síndrome metabólica foi identificada segundo o National Cholesterol Education Program. As análises estatísticas foram realizadas utilizando o programa estatístico R, com nível de significância de 5%. Resultados: A amostra foi composta por 173 pacientes, maioria do sexo feminino (53,2%) e diagnóstico de mieloma múltiplo (54,9%). A síndrome metabólica foi diagnosticada em 53,4% (n=79) dos pacientes. Encontrou-se circunferência da cintura elevada em 65,7%, hipertrigliceridemia em 50,3%, pressão arterial sistólica elevada em 49,7%, HDL-c baixo em 49%, pressão arterial diastólica elevada em 38,7% e hiperglicemia em 12,4%. A obesidade abdominal esteve mais associada ao género feminino (p< 0,001). Encontrou-se significativamente, maior média de idade no grupo diagnosticado com síndrome metabólica, obesidade abdominal, pressão arterial sistólica alta e hipertrigliceridemia (p< 0,05). A presença de infecção durante o internamento foi associada significativamente a pressão diastólica alta (p= 0,022). Não foram encontradas associações significativas entre a síndrome metabólica ou seus componentes com o tempo de hospitalização. Conclusões: Este estudo revelou alta prevalência de síndrome metabólica e de seus componentes em pacientes submetidos ao transplante de células-tronco hematopoiéticas autólogo. Entretanto, não foi encontrada associação entre a síndrome metabólica e o tempo de hospitalização.
- Open Access
- 3 February 2025
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 28 (1)
Liver Transplantation in Alpha-1 Antitrypsin Deficiency: A Retrospective Case-Control Study in a Brazilian Center
Objectives: Alpha-1 antitrypsin deficiency (AATD) is a rare genetic metabolic disease curable with liver transplantation (LT). The aim of this study was to comparatively evaluate patients with LT due to AATD and other causes. Methods: Observational, retrospective, analytical, case-control study evaluating 2,511 LT patients, 19 (0.75%) with AATD, from May 2002 to December 2024. Data were obtained by reviewing the medical records and stored in the REDCap program. Results: The median age of AATD and non-AATD (NAATD) patients was similar (56.3 [Δ7-71] and 52.4 [Δ6-78]; p = 0.92, respectively). Males predominated in both groups. The pre-LT Model for End-Stage Liver Disease (MELD)-Na scores for AATD and NAATD patients were 20 (Δ8-24) and 18 (Δ6-72), respectively. Two patients with AATD had positive serologies compatible with previous hepatitis B infection. Three patients also had a clinical epidemiological diagnosis of concomitant nonalcoholic fatty liver disease. The diagnosis of AATD was made only through explant in nine patients (n = 47.4%). The mean pre-transplant alpha-1 antitrypsin dosage was 33.42 mg/dL (Δ19-59.5). All patients who underwent immunophenotyping had the PiZZ phenotype. The indication for LT was decompensated cirrhosis (DC); three patients (16.4%) had concomitant hepatocellular carcinoma (HCC), one diagnosed only in the explant. The incidence of HCC was 15.9% (AATD) and 31.3% (NAATD) (p = 0.34). None of the patients with AATD had severe lung disease. The survival of patients with AATD submitted to LT at 30 days, 1, and 5 years was 94.7, 88.2, and 64.7%, respectively, similar to the other causes (91.4, 80.1, and 68.1%; p = 0.47). Conclusion: AATD was a rare cause of LT due to DC and HCC, predominantly in adults with piZZ phenotype without relevant pulmonary involvement, and whose diagnosis is frequently made after LT. The epidemiology, indication, prevalence of HCC, and survival were similar to those of other causes of LT.
- 3 February 2025
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 28 (1)
Open AccessLiver Transplantation in Alpha-1 Antitrypsin Deficiency: A Retrospective Case-Control Study in a Brazilian Center
Objectives: Alpha-1 antitrypsin deficiency (AATD) is a rare genetic metabolic disease curable with liver transplantation (LT). The aim of this study was to comparatively evaluate patients with LT due to AATD and other causes. Methods: Observational, retrospective, analytical, case-control study evaluating 2,511 LT patients, 19 (0.75%) with AATD, from May 2002 to December 2024. Data were obtained by reviewing the medical records and stored in the REDCap program. Results: The median age of AATD and non-AATD (NAATD) patients was similar (56.3 [Δ7-71] and 52.4 [Δ6-78]; p = 0.92, respectively). Males predominated in both groups. The pre-LT Model for End-Stage Liver Disease (MELD)-Na scores for AATD and NAATD patients were 20 (Δ8-24) and 18 (Δ6-72), respectively. Two patients with AATD had positive serologies compatible with previous hepatitis B infection. Three patients also had a clinical epidemiological diagnosis of concomitant nonalcoholic fatty liver disease. The diagnosis of AATD was made only through explant in nine patients (n = 47.4%). The mean pre-transplant alpha-1 antitrypsin dosage was 33.42 mg/dL (Δ19-59.5). All patients who underwent immunophenotyping had the PiZZ phenotype. The indication for LT was decompensated cirrhosis (DC); three patients (16.4%) had concomitant hepatocellular carcinoma (HCC), one diagnosed only in the explant. The incidence of HCC was 15.9% (AATD) and 31.3% (NAATD) (p = 0.34). None of the patients with AATD had severe lung disease. The survival of patients with AATD submitted to LT at 30 days, 1, and 5 years was 94.7, 88.2, and 64.7%, respectively, similar to the other causes (91.4, 80.1, and 68.1%; p = 0.47). Conclusion: AATD was a rare cause of LT due to DC and HCC, predominantly in adults with piZZ phenotype without relevant pulmonary involvement, and whose diagnosis is frequently made after LT. The epidemiology, indication, prevalence of HCC, and survival were similar to those of other causes of LT.
- Open Access
- 3 February 2025
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 28 (1)
Transplante de Fígado na Deficiência de Alfa-1 Antitripsina: Estudo Caso-Controle Retrospectivo em um Centro Brasileiro
Objetivos: A deficiência de alfa-1 antitripsina (DAAT) é uma doença metabólica genética rara curável com transplante hepático (TH). O objetivo deste estudo foi avaliar comparativamente pacientes com TH por DAAT e outras causas. Métodos: Estudo observacional, retrospectivo, analítico, caso-controle, avaliando 2.511 pacientes com TH, 19 (0,75%) com DAAT, no período de maio de 2002 a dezembro de 2024. Os dados foram obtidos por meio da revisão dos prontuários e armazenados no programa REDCap. Resultados: A mediana de idade dos pacientes com e sem AATD (NAATD) foi semelhante [56,3 (Δ7-71) e 52,4 (Δ6-78); p = 0,92, respectivamente). O sexo masculino predominou em ambos os grupos. O modelo pré-TH para doença hepática terminal Model for End-Stage Liver Disease (MELD)-Na dos pacientes com DAAT e NDAAT foi de 20 (Δ8-24) e 18 (Δ6-72), respectivamente. Dois pacientes com DAAT apresentaram sorologias positivas compatíveis com infecção prévia por hepatite B. Três pacientes também apresentaram diagnóstico clínico e epidemiológico de doença hepática gordurosa não alcoólica concomitante. O diagnóstico de DAAT foi feito apenas por explante em nove pacientes (n = 47,4%). A dosagem média de DAAT pré-transplante foi de 33,42 mg/dL (Δ19-59,5). Todos os pacientes submetidos à imunofenotipagem apresentaram fenótipo PiZZ. A indicação para TH foi cirrose descompensada (CD); três pacientes (16,4%) apresentaram carcinoma hepatocelular (CHC) concomitante, um diagnosticado apenas no explante. A incidência de CHC foi de 15,9% (DAAT) e 31,3% (NDAAT) (p = 0,34). Nenhum dos pacientes com DAAT apresentou doença pulmonar grave. A sobrevida dos pacientes com DAAT submetidos a TH em 30 dias, 1 e 5 anos foi de 94,7; 88,2 e 64,7%, respectivamente, semelhante às outras causas (91,4, 80,1 e 68,1%; p = 0,47). Conclusão: A DAAT foi uma causa rara de TH devido à CD e CHC, predominantemente em adultos com fenótipo piZZ sem envolvimento pulmonar relevante e cujo diagnóstico é frequentemente feito após TH. A epidemiologia, indicação, prevalência de CHC e sobrevida foram semelhantes a outras causas de TH.
- 3 February 2025
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 28 (1)
Open AccessTransplante de Fígado na Deficiência de Alfa-1 Antitripsina: Estudo Caso-Controle Retrospectivo em um Centro Brasileiro
Objetivos: A deficiência de alfa-1 antitripsina (DAAT) é uma doença metabólica genética rara curável com transplante hepático (TH). O objetivo deste estudo foi avaliar comparativamente pacientes com TH por DAAT e outras causas. Métodos: Estudo observacional, retrospectivo, analítico, caso-controle, avaliando 2.511 pacientes com TH, 19 (0,75%) com DAAT, no período de maio de 2002 a dezembro de 2024. Os dados foram obtidos por meio da revisão dos prontuários e armazenados no programa REDCap. Resultados: A mediana de idade dos pacientes com e sem AATD (NAATD) foi semelhante [56,3 (Δ7-71) e 52,4 (Δ6-78); p = 0,92, respectivamente). O sexo masculino predominou em ambos os grupos. O modelo pré-TH para doença hepática terminal Model for End-Stage Liver Disease (MELD)-Na dos pacientes com DAAT e NDAAT foi de 20 (Δ8-24) e 18 (Δ6-72), respectivamente. Dois pacientes com DAAT apresentaram sorologias positivas compatíveis com infecção prévia por hepatite B. Três pacientes também apresentaram diagnóstico clínico e epidemiológico de doença hepática gordurosa não alcoólica concomitante. O diagnóstico de DAAT foi feito apenas por explante em nove pacientes (n = 47,4%). A dosagem média de DAAT pré-transplante foi de 33,42 mg/dL (Δ19-59,5). Todos os pacientes submetidos à imunofenotipagem apresentaram fenótipo PiZZ. A indicação para TH foi cirrose descompensada (CD); três pacientes (16,4%) apresentaram carcinoma hepatocelular (CHC) concomitante, um diagnosticado apenas no explante. A incidência de CHC foi de 15,9% (DAAT) e 31,3% (NDAAT) (p = 0,34). Nenhum dos pacientes com DAAT apresentou doença pulmonar grave. A sobrevida dos pacientes com DAAT submetidos a TH em 30 dias, 1 e 5 anos foi de 94,7; 88,2 e 64,7%, respectivamente, semelhante às outras causas (91,4, 80,1 e 68,1%; p = 0,47). Conclusão: A DAAT foi uma causa rara de TH devido à CD e CHC, predominantemente em adultos com fenótipo piZZ sem envolvimento pulmonar relevante e cujo diagnóstico é frequentemente feito após TH. A epidemiologia, indicação, prevalência de CHC e sobrevida foram semelhantes a outras causas de TH.
- Open Access
- 12 November 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (5) , e20240299
CPAP delivered via a helmet interface in lightly sedated patients with moderate to severe ARDS: predictors of success outside the ICU
Objective: This study aimed to describe the outcomes and explore predictors of intubation and mortality in patients with ARDS due to COVID-19 treated with CPAP delivered via a helmet interface and light sedation. Methods: This was a retrospective cohort study involving patients with COVID-19-related ARDS who received CPAP using a helmet developed in Brazil (ELMOT), associated with a light sedation protocol in a pulmonology ward. Demographic, clinical, imaging, and laboratory data, as well as the duration and response to the ELMO-CPAP sessions, were analyzed. Results: The sample comprised 180 patients. The intubation avoidance rate was 72.8%. The lack of necessity for intubation was positively correlated with younger age, > 24-h continuous HELMET-CPAP use in the first session, < 75% pulmonary involvement on CT, and ROX index > 4.88 in the second hour. The overall in-hospital mortality rate was 18.9%, whereas those in the nonintubated and intubated groups were 3.0% and 61.2%, respectively. Advanced age increased the mortality risk by 2.8 times, escalating to 13 times post-intubation. Conclusions: ELMO-CPAP with light sedation in a pulmonology ward was successful in > 70% of patients with moderate to severe ARDS due to COVID-19. Younger age, pulmonary involvement, ROX index, and prolonged first Helmet-CPAP session duration were associated with no need for intubation. Older age and intubation are associated with mortality.
- 12 November 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (5) , e20240299
Open AccessCPAP delivered via a helmet interface in lightly sedated patients with moderate to severe ARDS: predictors of success outside the ICU
Objective: This study aimed to describe the outcomes and explore predictors of intubation and mortality in patients with ARDS due to COVID-19 treated with CPAP delivered via a helmet interface and light sedation. Methods: This was a retrospective cohort study involving patients with COVID-19-related ARDS who received CPAP using a helmet developed in Brazil (ELMOT), associated with a light sedation protocol in a pulmonology ward. Demographic, clinical, imaging, and laboratory data, as well as the duration and response to the ELMO-CPAP sessions, were analyzed. Results: The sample comprised 180 patients. The intubation avoidance rate was 72.8%. The lack of necessity for intubation was positively correlated with younger age, > 24-h continuous HELMET-CPAP use in the first session, < 75% pulmonary involvement on CT, and ROX index > 4.88 in the second hour. The overall in-hospital mortality rate was 18.9%, whereas those in the nonintubated and intubated groups were 3.0% and 61.2%, respectively. Advanced age increased the mortality risk by 2.8 times, escalating to 13 times post-intubation. Conclusions: ELMO-CPAP with light sedation in a pulmonology ward was successful in > 70% of patients with moderate to severe ARDS due to COVID-19. Younger age, pulmonary involvement, ROX index, and prolonged first Helmet-CPAP session duration were associated with no need for intubation. Older age and intubation are associated with mortality.
- Open Access
- 27 June 2024
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 46
The impact of surgical treatment for deep endometriosis: metabolic profile, quality of life and psychological aspects
Objective To evaluate the effects of surgical treatment of deep endometriosis on the metabolic profile, quality of life and psychological aspects. Methods Prospective observational study, carried out with women of reproductive age diagnosed with deep endometriosis, treated in a specialized outpatient clinic, from October/2020 to September/2022, at a University Hospital in Fortaleza – Brazil. […] Abstract Objective To evaluate the effects of surgical treatment of deep endometriosis on the metabolic profile, quality of life and psychological aspects. Methods Prospective observational study, carried out with women of reproductive age diagnosed with deep endometriosis, treated in a specialized outpatient clinic, from October/2020 to September/2022, at a University Hospital in Fortaleza – Brazil. […]
- 27 June 2024
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 46
Open AccessThe impact of surgical treatment for deep endometriosis: metabolic profile, quality of life and psychological aspects
Objective To evaluate the effects of surgical treatment of deep endometriosis on the metabolic profile, quality of life and psychological aspects. Methods Prospective observational study, carried out with women of reproductive age diagnosed with deep endometriosis, treated in a specialized outpatient clinic, from October/2020 to September/2022, at a University Hospital in Fortaleza – Brazil. […] Abstract Objective To evaluate the effects of surgical treatment of deep endometriosis on the metabolic profile, quality of life and psychological aspects. Methods Prospective observational study, carried out with women of reproductive age diagnosed with deep endometriosis, treated in a specialized outpatient clinic, from October/2020 to September/2022, at a University Hospital in Fortaleza – Brazil. […]